Skip to content
CityAM
Main navigation
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Tech
      • Banking
      • FTSE 100 Live
      • Retail
      • Insurance
      • Legal
      • Property
      • Transport
      • Markets
    • From our partners
      • AON
      • Bayes Business School
      • Canada BIDs
      • Central London Alliance CIC
      • Destination City
      • Halkin
      • Olympia
      • Inside Saudi
      • Tottenham Hotspur Stadium
      • Santander X
      • YEAR SIX Dividend
    • Featured

      Serco hits back after Zia Yusuf accuses FTSE 250 firm of being ‘hostile to Reform’

      Former Chairman of Reform UK, Zia Yusuf addresses Reform UK supporters.

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
    • From our partners
      • The Morning Briefing: SBS x CityAM
      • Aramco Team Series
      • LIV Golf
    • Featured

      Royal Ascot worth £140m to UK economy

      Breaking news scene with journalists and cameras outside a government building, capturing a press conference in progress.

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • Toast the City Awards
      • The Magazine
      • Travel
      • Culture
      • Motoring
      • Wellness
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      The best places to eat sandwiches in Lisbon, from bifanas to pregos

      Bifana do Afonsos famous bifana sandwich showcasing tender pork in a freshly baked roll with savory sauce.

      Submit a story

      Tell us your story.

      Submit
  • Investec
  • Events
  • Latest Paper
Monday 14 August 2023 3:13 pm

Explainer: An overhaul of cancer targets causes split between doctors

By: Elena Siniscalco

Add as a preferred source on Google

Today NHS England announced proposals for new cancer targets following a consultation that began last year. The proposals include significant changes, like abolishing around two-thirds of the targets and changing others in a major overhaul of the cancer diagnostics and treatment system.

The NHS says the new system, with fewer targets, will be easier for patients to understand. The main targets will come down to three. 

Patients who have suspected cancer – which means they show potential symptoms – will get a diagnosis or an all-clear within 28 days. Historically, the targets here have always specified the patient needed to see a specialist.

Secondly, patients with a diagnosis will start treatment within nine weeks from the date of referral. 

And lastly, the timeline to receive the first treatment for cancer patients should be within a month of a decision to treat the diagnosis. 

Practitioners in the field disagreed on whether the changes made much of a positive difference, given that cancer targets have been routinely missed for a while. 

Speaking on Radio 4 this morning, Dr Tom Roques, vice president of clinical oncology at the Royal College of Radiologists, welcomed the targets. He said they focus on the two important things for cancer patients: getting a diagnosis quickly and starting treatment quickly.

He said the target for seeing a specialist didn’t make sense anymore, given the use of technologies like teledermatology to look at skin symptoms or endoscopy tests to detect the presence – or lack of – bowel cancer.  

Read more

Anocca has Dosed First Patients with Precision TCR-T Cell Therapy Targeting Mutant KRAS in Pancreatic Cancer

“The artificial focus on ‘you need to see a doctor within 14 days’ might not be the best way”, he said.

He did acknowledge, however, that targets “achieve nothing on their own”, calling for more investment in the workforce. 

Professor Pat Price, co-founder of the #CatchupWithCancer campaign, was much more cynical about the new targets. She pointed to the lack of evidence that these changes will affect performance, saying “failure is failure however you measure it”. 

“Just changing targets could make a small change, we’ll see, but we don’t need small changes, we’re in the biggest cancer crisis we have”, she said. 

Professor Price pointed to one of the most contested aspects of the changes, the one on breast cancer. The current target is for 93 per cent of women to be seen in a one-stop clinic in 2 weeks. The actual figure achieved by the NHS currently stands at around 74 per cent, and the new target will be for 75 per cent of women to be seen in 28 days. 

The changes have political weight as well, as the results of the consultation are subjected to final approval by ministers.

Labour was quick to accuse the government of moving the goalposts after repeated failures at doing something to help the NHS reach its targets. Keir Starmer said that the last Labour government “hit those targets”. “We didn’t walk away when the going got tough”, he said. 

Health secretary Steve Barclay insisted ministers weren’t behind the drive to change the targets, saying it was driven instead by clinical leaders within the field.

Read more

Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Selects MEVION S250-FIT™ for Southern Italy’s First Proton Therapy Center

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Opinion

Categories

  • Opinion

Trending Articles

  • London Tech Week sums up everything wrong with UK tech

  • Inflation expectations at record high in interest rates signal

  • As it happened: FTSE 100 relief rally runs out of steam as BP and Shell weigh; Oil hits three-month low

  • KPMG’s Summer Friday half-day rollback signals deeper woes for Big Four giants

  • New Gluten-Free Bread Binder Simplifies the Recipe — and Boosts Bread Quality

More from CityAM

  • Anocca has Dosed First Patients with Precision TCR-T Cell Therapy Targeting Mutant KRAS in Pancreatic Cancer

    Business Wire
  • Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Selects MEVION S250-FIT™ for Southern Italy’s First Proton Therapy Center

    Business Wire
  • Gustave Roussy and One Biosciences Partner to Bring Single Cell to Clinical Practice for Precision Oncology

    Business Wire
  • Mevion Introduces the First Proton Therapy System Designed for a LINAC Vault at ESTRO 2026

    Business Wire
  • GSK shares slip after buying US cancer treatment firm Nuvalent for $10.6bn

    Pharma
    GSK logo displayed prominently, signifying the companys presence and relevance in the business and healthcare sectors.
  • Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera

    Business Wire
  • CellCentric Announces Oversubscribed $220 Million Series D Financing to Advance Pivotal Trials of Inobrodib in Multiple Myeloma

    Business Wire
  • Reply and IEO Launch Collaboration to Co-Develop and Train Domain-Specific Large Language Models for Oncology

    Business Wire
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • News
  • Markets & Economics
  • Politics
  • Opinion
  • Life&Style
  • Personal Finance

Follow us for breaking news and latest updates

  • Facebook
  • X
  • Instagram
  • LinkedIn
Copyright 2026 CityAM Limited